Abstract
Beyond endothelial NO production through ecNOS (type III NOS), there is increasing evidence for a different mechanism of NO formation via the inducible NO synthase (iNOS or type II NOS) in a variety of cells, including vascular endothelial and smooth muscle cells.11,3,1,2,6,27 This enzyme also uses L-arginine as substrate and is sensitive to inhibitory L-arginine analogues; furthermore, it does not appear to differ significantly from ecNOS on the basis of cofactor requirements.17 It can be distinguished, however, by the major characteristics of its activation. In contrast to the endothelial, rapidly responsive constitutive pathway, the activity of the inducible pathway is generally calcium and calmodulin independent, slow in onset, occurs after a delay of several hours, it is transcriptionally regulated and sensitive to dexamethasone.31
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Beasley, D., R. A. Cohen, and N. G. Levinsky. Interleukin-I inhibits contraction of vascular smooth muscle. J.Clin. Invest. 83:331–335, 1989.
Beasley, D., J. H. Schwartz, and B. M. Brenner. Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J. Clin. Invest. 87:602–608, 1991.
Beasley, D. Interleukin 1 and endotoxin activate soluble guanylate cyclase in vascular smooth muscle. Am. J. Physiol. 259:R38–R44, 1990.
Bradford, M. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–253.
Breitfeld, P. P., McKinnon, W. C., and Mostov, K. E. (1990) J. Cell Biol. 111, 2365.
Busse, R. and Mulsch, A. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS LeUers 275:87–90, 1990.
Cantley, L.C., Auger, K.R., Carpenter, C., Duckworth, B., Graziani, A., Kapeller, R. and Soltoff, S. Oncogenes and signal transduction. Cell 64:281–302, 1991.
Carter K.C., Cooper, R., Papaconstantinou, J. and Ritchie, D.G. Microtubule Depolymerization inhibits the regulation of a,-acid glycoprotein MRNA by hepatocyte stimulating factor. J. Biol. Chem. 264:515–519, 1989.
Ding, A. H., Porteu, F., Sanchez, E. and Nathan, C. F. Shared actions of endotoxin and taxoi: induction of TNF release and downregulation of TNF receptors. Science 248:370–372,1992.
Ding, A.H., Porteu, F., Sanchez, E. and Nathan, C.F. Down-regulation of tumor necrosis factor receptors on macrophages and endothelial cells by microtubule depolymerizing agents. J.Exp. Med. 171, 715–727, 1990.
Fleming, I., G. A. Gray, G. Julou-Schaeffer, J. R. Parratt and J. Stoclet. Incubation with endotoxin activates the L-arginine pathway in vascular tissue. Biochem. Biophys. Res. Commun. 171:562–568, 1990.
Garland, D. L. (1978) Biochemistry. 17, 4266.
Geinsterfer, A. A. T., M. J. Peach, and G. Owens. Angiotensin 11 induces hypertrophy but not hyperplasia of cultured rat aortic smooth muscle cells. Circ. Res. 62: 749–756, 1988.
Geroulanos, S., Schilling, J., Cakmakci, M., Jung, H.H., and Largiader, F. (1992) Inhibition of NO synthesis in septic shock. Lancet. 339, 434–435.
Hortelano, S., A. M. Genaro, and L. Bosca. Phorbol esters induce nitric oxide synthase activity in rat hepatocytes. J. Biol. Chem. 267: 24937–24940, 1992.
Kilbourne, R.G. and P. Belloni. Endothelial cell production of nitrogen oxides in response to interferon in combination with tumor necrosis factor, interleukin-1, or endotoxin. J. Natt. Cancer Inst. 82:772–776, 1990.
Knowles, R.G. and Moncada, S. Nitric oxide as a signal in blood vessels. TIBS 17:399–402, 1992.
Lee, J. C., Fleld, D. J., and Lee, L. L. Y. (1980) Biochemistry. 19, 6209.
Lorente, J.A., Landin, L., De Pablo, R., Renes, E. and Liste D. L-arginiiie pathway in sepsis syndrome. Ciitical Care Medicine 21(No 9): 1287–1295, 1993.
Munoz, E., Zublaga, A., Huang, C-K and Huber, B.T. Interleukin-I induces protein tyrosine phosphorylation in T cells. Eur. J. Immunol. 22:1391–1396, 1992.
Ochoa, J.B., Udekwu, A.O., Billar, T.R., et al. 1991. Nitrogen oxide levels in patients after trauma and sepsis. Ann. Surg. 214:621–626.
Otto, A.M., Zumbe, A., Gibson, L., Kubier, A. and de Asua, L.J. Cytoskeleton-disrupting drugs enhance effect of growth factors and hormones on initiation of DNA synthesis. Proc. Natl Acad. Sci. U. S.A. 76:6435–6438, 1979.
Petros, A., Bennett, D., and Vallance P. (1991) Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet. 338, 1557–1558.
Ryan J.W. & Ryan U.S. Endothelial surface enzymes and the processing of plasma substrates. Int.Rev.Exp.Pathol. 26:1, 1984.
Santell, L., Marotti, K., Bartfeld, N.S., Baynham, P. and Levin E.G. Disruption of microtubules inhibits the stimulation of tissue plasminogen adtivator expression and promotes plasminogen activator inhibitor type I expression in human endothelial cells. Exp. Cell Res. 201:358–365, 1992.
Schiff, P.B., Fant, J., and Horwitz, S.B. (1979) Nature. 277, 665–667.
Schini, V. B., D. C. Junquero, T. Scott-Burden, and P. M. Vanhoutte. Interieukin-1 b inducesthe production of an L-arginine-derived relaxing factor from cultured smooth muscle cells from rat aorta. Biochem. Biophys. Res. Conunun. 176:114–121, 1991.
Corbett, J.A., M.A. Sweetland, J.R. Lancaster Jr., and M.L. McDaniel. A 1-hour pulse with IL-1 induces formation of nitric oxide and inhibits insulin secretion by rat islets of L.angerhans: evidence for a tyrosine kinase signaling mechanism. FASEB J. 7:369–374, 1993.
Di Salvo, J., A. Steusloff, L. Semenchuk, S. Satoh, K. Kolquist and G. Pfizer. Tyrosine kinase inhibitors supress agonist-induced contraction in smooth muscle. Biochem. Biophys. Res.Commun. 190, 968–974, 1993.
Penman, S., D. G. Capco, E. G. Fey, P. Chatterjee, T. Reiter, S. Ermish and K. Wan. The three-dimensional structural networks of cytoplasm and nucleus: Function in cells and tissue. Modern Cell Biol. 2:385–415, 1983.
Xie, Q., Cho, H.J., Calaycay, J., Mumford, R.A., Swiderek, K.M., Lee, T.D., Ding, A., Troso, T. and Nathan, C. Cloning and characterization of inducible nitirc oxide synthase from mouse macrophages. Science 256:225–228, 1992.
Evans, T., Carpenter, A., and Cohen, J. Inducible nitric-oxide-syntase mRNA is transiently expressed and destroyed by a cycleheximide-sensitive process. Eur. J. Biochem. 219:563–569, 1994.
Brooker G., Terasake, W., and Price, M. Gammaflow: A completely automated radioimmunoassay system. Science 194:270–276, 1976.
Meyer, M., Schreck R. and Bauerie, P.A. H202 and antioxidants have opposite effects on activation of NF-KB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. ne EMBO Journal:2005-2015.
Devary, Y., Gottlieb, R.A., Smeal, T. and Karin, M. The Mammalian Ultraviolet Response IsTriggered by Activation of Src Tyrosine Kinases. Cell 71:1081–1091, 1992.
Coyne, D.W., and A. R. Morrison. Effect of the tyrosine kinase inhibitor-, genistein, on interleukin-I stimulated PGE, production in mesangial cells. Biochem. Biophys. Res. Commun. 173: 718–724, 1990.
Catravas, J.D. and Watkins, C.A. Plasmalemmal metabolic activities in cultured calf pulmonary arterial endothelial cells. Res.Commun. Chemic. Path. Pharmacol. 50:163–179.
Hunter, W.M. and Greenwood, F.C. Preparation of iodine-131 labeled juman growth hormone of high specific activity. Nature, 194;495–496, 1962.
Patel, A. and Linden, J. Purification of 125I-lbeled succinyl cyclic nucleotide tyrosine methyl esters by high-performance liquid chromatography. Anal Biochem., 168:417–420, 1988.
Corbett, J.A., Sweetland, M.A., Lancaster, J.R., Jr., and McDaniel, M.L. A 1-hour pulse with IL-1β induces formation of nitric oxide and inhibits insulin secretion by rat isles of Langerhans: evidence for a tyorsine kinase signaling mechanism. Faseb J. 7:369–374, 1993.
Unemori, E.N. and Werb, Z.J. Reorganization of polymerized actin: a possible trigger for induction of procollagenase in fibroblasts cultured in and on collagen gels. J. Cell Biol., 103; 1021–1031, 1986.
Botteri, F.M., ballmer-Hofer, K., Rajput, B., and Nagamine, Y. Disruption of cytoskeletal structures results in the induction of the urokinase type plasminogen activator gene expression. J. Biol. Chem., 265:13327–13334, 1990.
Walker, P.R. and Whitfield, J.F. Cytoplasmic microtubules are essential for the formatin of membrane bound polyribosomes. J. Biol. Chem., 260:765–770, 1985.
Sundell, C.L., and Singer, R.H. Requirement of microfilaments in sorting of actin mRNA. Science, 253:1275–1277,1991.
Birchmeier, W. Cytoskeleton structure and function. Trends Biochem. Sci., 9:192–195, 1984.
Marczin, N., Papapetropoulos, A., and Catravas, J.D. Tyrosine kinase inhibitors suppress endotoxin-and IL-1β-induced NO synthesis in aortic smooth muscle cells. Am.Physiol.Soc. H1014-H1018, 1993.
Marczin, N., Jilling, T., Papapetropoulos, A., Go C., and Catravas, J.D. Cytoskeleton-dependent activation of the inducible nitric oxide synthase in cultured aortic smooth muscle cells. British J. Pharmacol. 118:1085–1094, 1996.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Catravas, J.D., Marczin, N. (1998). Control of iNOS Expression in Rat Aortic Smooth Muscle Cells. In: Catravas, J.D., Callow, A.D., Ryan, U.S. (eds) Vascular Endothelium. NATO ASI Series, vol 294. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0133-0_4
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0133-0_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0135-4
Online ISBN: 978-1-4899-0133-0
eBook Packages: Springer Book Archive